Insider Transactions in Q1 2021 at Cme Group Inc. (CME)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,120
+12.64%
|
$222,480
$54.37 P/Share
|
|
Mar 16
2021
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.72%
|
$16,146
$207.12 P/Share
|
|
Mar 15
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,732
-5.47%
|
$570,988
$209.09 P/Share
|
|
Mar 15
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
BUY
Grant, award, or other acquisition
|
Direct |
7,048
+12.37%
|
$1,473,032
$209.09 P/Share
|
|
Mar 15
2021
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,186
-7.19%
|
$665,874
$209.09 P/Share
|
|
Mar 15
2021
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,990
+15.28%
|
$1,669,910
$209.09 P/Share
|
|
Mar 15
2021
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,574
-14.71%
|
$3,045,966
$209.09 P/Share
|
|
Mar 15
2021
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
32,896
+24.93%
|
$6,875,264
$209.09 P/Share
|
|
Mar 15
2021
|
Bryan T Durkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,975
-6.93%
|
$1,248,775
$209.09 P/Share
|
|
Mar 15
2021
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,038
+14.86%
|
$3,142,942
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-7.44%
|
$713,526
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+15.56%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-4.39%
|
$713,526
$209.09 P/Share
|
|
Mar 15
2021
|
Kevin Kometer Sr MD Chief Information Office |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+9.8%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-5.99%
|
$547,580
$209.09 P/Share
|
|
Mar 15
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,048
+13.87%
|
$1,473,032
$209.09 P/Share
|
|
Mar 15
2021
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,806
-7.36%
|
$795,454
$209.09 P/Share
|
|
Mar 15
2021
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,398
+15.37%
|
$1,964,182
$209.09 P/Share
|
|
Mar 15
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-18.1%
|
$662,112
$209.09 P/Share
|
|
Mar 15
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
7,990
+31.34%
|
$1,669,910
$209.09 P/Share
|
|
Mar 15
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-1.12%
|
$45,144
$209.09 P/Share
|
|
Mar 15
2021
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
734
+3.67%
|
$153,406
$209.09 P/Share
|
|
Mar 15
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,771
-13.41%
|
$788,139
$209.09 P/Share
|
|
Mar 15
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Grant, award, or other acquisition
|
Direct |
8,460
+23.12%
|
$1,768,140
$209.09 P/Share
|
|
Mar 15
2021
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-3.46%
|
$80,883
$209.09 P/Share
|
|
Mar 15
2021
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,316
+10.52%
|
$275,044
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-4.14%
|
$543,191
$209.09 P/Share
|
|
Mar 15
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,578
+17.28%
|
$1,374,802
$209.09 P/Share
|
|
Mar 11
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,500
-5.1%
|
$307,500
$205.46 P/Share
|
|
Mar 05
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.93%
|
$319,500
$213.0 P/Share
|
|
Feb 26
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
10,000
-18.56%
|
$2,010,000
$201.4 P/Share
|
|
Feb 26
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Open market or private sale
|
Indirect |
7,335
-17.14%
|
$1,459,665
$199.09 P/Share
|
|
Feb 19
2021
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Open market or private sale
|
Direct |
8,000
-3.52%
|
$1,560,000
$195.93 P/Share
|
|
Feb 19
2021
|
Bryan T Durkin Director |
SELL
Open market or private sale
|
Direct |
11,000
-6.91%
|
$2,145,000
$195.72 P/Share
|
|
Feb 12
2021
|
Dennis Suskind Director |
SELL
Open market or private sale
|
Direct |
1,000
-28.05%
|
$183,000
$183.32 P/Share
|
|
Jan 07
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.78%
|
$297,000
$198.0 P/Share
|